Chugai Pharmaceutical Co., Ltd.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (5)
Compared with Healthcare companies in Japan.
P/E ratio
23.1Investors pay 23.1 for every 1 of Chugai Pharmaceutical Co., Ltd.'s yearly profit, higher than 82% of Healthcare companies in Japan.
P/B ratio
5.44The share price is 5.44 times Chugai Pharmaceutical Co., Ltd.'s book value per share, higher than 95% of Healthcare companies in Japan.
Market cap
¥11,030.3 BThe total market value of all of Chugai Pharmaceutical Co., Ltd.'s shares at today's price (share price × number of shares), larger than almost all Healthcare companies in Japan. PosiCap size class: Tito Cap.
Return on equity (ROE)
23.5%Chugai Pharmaceutical Co., Ltd. earned 23.5% on its shareholders' money over the last year, higher than 96% of Healthcare companies in Japan.
Dividend yield
1.94%Chugai Pharmaceutical Co., Ltd. pays 1.94% of its share price as dividends a year, lower than 78% of dividend-paying Healthcare companies in Japan.
Questions
What is Chugai Pharmaceutical Co., Ltd.'s P/E ratio?
Investors pay 23.1 for every 1 of Chugai Pharmaceutical Co., Ltd.'s yearly profit, higher than 82% of Healthcare companies in Japan.
What is Chugai Pharmaceutical Co., Ltd.'s return on equity?
Chugai Pharmaceutical Co., Ltd. earned 23.5% on its shareholders' money over the last year, higher than 96% of Healthcare companies in Japan.
Does Chugai Pharmaceutical Co., Ltd. pay a dividend?
Yes. Chugai Pharmaceutical Co., Ltd. pays 1.94% of its share price as dividends a year, lower than 78% of dividend-paying Healthcare companies in Japan.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.